2020年11月27日
Global Data Hub – 10 / 17 观点
Privacy issues around health data have come into sharp relief during the COVID-19 pandemic, focused on the race to develop an effective test and trace system and a vaccine.
Whether health data is processed by medical devices, in databases or paper files, protection of this sensitive information is vital. We look at some key regulatory requirements in the UK, France and Germany:
Mary Rendle looks at the regulatory framework for medical devices processing NHS health data.
Vin Bange and Debbie Heywood consider the exemptions and restrictions that apply to health data-related subject access requests.
Thanos Rammos looks at the new regulatory regime for digital healthcare and 'apps by prescription' in Germany.
Jo Joyce looks at the privacy issues involved in developing contact tracing apps and whether they impact their ultimate success.
Sally Annereau looks at the proposed changes to the Caldicott Principles which aim to maintain future relevance
Nolwenn Vignaud looks at rules around processing health data in France and at their impact on transfers of health data to the USA.
Helen Farr looks at the data protection implications of the EU Whistleblowing Directive and whistleblower hotlines more generally.
2022年7月11日
作者 Helen Farr
Anna Taylor and Jo Joyce look at the data sharing requirements for the proposed pensions dashboard and resulting data protection considerations.
2022年5月17日
作者 Anna Taylor, Jo Joyce
2022年2月14日
作者 作者